chr4-154236719-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_001358235.2(DCHS2):āc.7933T>Cā(p.Leu2645=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0111 in 1,613,906 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.0077 ( 8 hom., cov: 32)
Exomes š: 0.012 ( 111 hom. )
Consequence
DCHS2
NM_001358235.2 synonymous
NM_001358235.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.318
Genes affected
DCHS2 (HGNC:23111): (dachsous cadherin-related 2) This gene encodes a large protein that contains many cadherin domains and likely functions in cell adhesion. Genome-wide association studies suggest that this gene may be important in Alzheimer's disease, compressive strength index, and appendicular lean mass. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 4-154236719-A-G is Benign according to our data. Variant chr4-154236719-A-G is described in ClinVar as [Benign]. Clinvar id is 3038093.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.318 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCHS2 | NM_001358235.2 | c.7933T>C | p.Leu2645= | synonymous_variant | 20/20 | ENST00000357232.10 | NP_001345164.1 | |
LOC101927947 | XR_007058336.1 | n.4255+29666A>G | intron_variant, non_coding_transcript_variant | |||||
LOC101927947 | XR_007058335.1 | n.689+29666A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCHS2 | ENST00000357232.10 | c.7933T>C | p.Leu2645= | synonymous_variant | 20/20 | 1 | NM_001358235.2 | ENSP00000349768 | P1 | |
ENST00000625026.1 | n.740A>G | non_coding_transcript_exon_variant | 1/1 | |||||||
ENST00000660197.1 | n.412+29666A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00767 AC: 1167AN: 152190Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1167
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00776 AC: 1942AN: 250260Hom.: 11 AF XY: 0.00793 AC XY: 1072AN XY: 135248
GnomAD3 exomes
AF:
AC:
1942
AN:
250260
Hom.:
AF XY:
AC XY:
1072
AN XY:
135248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0115 AC: 16811AN: 1461598Hom.: 111 Cov.: 34 AF XY: 0.0112 AC XY: 8154AN XY: 727102
GnomAD4 exome
AF:
AC:
16811
AN:
1461598
Hom.:
Cov.:
34
AF XY:
AC XY:
8154
AN XY:
727102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00766 AC: 1167AN: 152308Hom.: 8 Cov.: 32 AF XY: 0.00725 AC XY: 540AN XY: 74474
GnomAD4 genome
AF:
AC:
1167
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
540
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
DCHS2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 27, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at